|
Volumn 30, Issue 5, 2003, Pages 1124-1125
|
Fluvoxamine therapy for fibromyalgia [6]
|
Author keywords
[No Author keywords available]
|
Indexed keywords
AMITRIPTYLINE;
FLUVOXAMINE;
SEROTONIN UPTAKE INHIBITOR;
ADULT;
CHI SQUARE DISTRIBUTION;
CLINICAL ARTICLE;
CLINICAL FEATURE;
CLINICAL TRIAL;
CONSTIPATION;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DEPRESSION;
DISEASE ASSOCIATION;
DISEASE COURSE;
DOUBLE BLIND PROCEDURE;
DROWSINESS;
DRUG INDICATION;
DRUG WITHDRAWAL;
EPIGASTRIC PAIN;
FATIGUE;
FEMALE;
FIBROMYALGIA;
HEART PALPITATION;
HUMAN;
HYPERSOMNIA;
LETTER;
MALE;
NAUSEA;
OBSESSIVE COMPULSIVE DISORDER;
PAIN ASSESSMENT;
PRIORITY JOURNAL;
SEX RATIO;
SIDE EFFECT;
THIRST;
TREATMENT OUTCOME;
VERTIGO;
VISUAL ANALOG SCALE;
ANTIDEPRESSIVE AGENTS, SECOND-GENERATION;
FIBROMYALGIA;
FLUVOXAMINE;
HUMANS;
TREATMENT OUTCOME;
|
EID: 0037734326
PISSN: 0315162X
EISSN: None
Source Type: Journal
DOI: None Document Type: Letter |
Times cited : (5)
|
References (3)
|